Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial
Guoming Li(Guangzhou University of Chinese Medicine), Jianping Song(Kunming University of Science and Technology), Yueming Yuan(Huazhong Agricultural University), Yexiao Tang(Guangzhou University of Chinese Medicine), Xiangdong Guan(Xinjiang Medical University), Weisheng Yu(Guangzhou University of Chinese Medicine), Jin Chun-ming(Mudanjiang Medical University), Jia–Wen Guo(Air Force Medical University), Fengjie Xie(Mudanjiang Medical University), Qi Wang(Hebei Medical University), Hongying Zhang(Nanchang University), Haihong Li(Sun Yat-sen University), Qin Xu(University of Pittsburgh), Mei Yuan(Mudanjiang Medical University), Changsheng Deng(Guangzhou University of Chinese Medicine), Yuanyuan Zou(Guangzhou University of Chinese Medicine)
Cited by 62
Related Papers
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Highly Polarization-Sensitive, Broadband, Self-Powered Photodetector Based on Graphene/PdSe<sub>2</sub>/Germanium Heterojunction
|ACS Nano|2019|633
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease
|Journal of Structural Biology|2005|585
Ultrabroadband and High-Detectivity Photodetector Based on WS<sub>2</sub>/Ge Heterojunction through Defect Engineering and Interface Passivation
|ACS Nano|2021|482
Complex roles of cAMP–PKA–CREB signaling in cancer
|Experimental Hematology and Oncology|2020|469